FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to virology, and can be used in treatment of chronic viral hepatitis type C, genotype 3a. That is ensured by subcutaneous introduction of Ronkoleukin in dosage 0.5 mg once a week for 24-32 weeks with underlying administration vitamin B complex, hepatoprotectors and the antiviral therapy including intramuscular introduction of IFN-α in dosage 3 million IU 3 times week and per os administration of Ribavirin in a daily dose 800 mg.
EFFECT: method ensures a stable viral response due to intensified T-cell immunity link by restored synthesis of endogenous IL-2 with activated CD-4 and CD-8 lymphocytes, compensated deficiency of IL-2 production by mononuclear cells, restored and increased functional activity of target cells of endogenous IL-2: NK-cells, T-lymphocytes helpers, monocytes.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PROVIDING HIGHER EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2011 |
|
RU2468815C1 |
METHOD FOR TREATING PATIENTS FOR VIRAL HEPATITIS C | 2002 |
|
RU2212248C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD FOR PREDICTION OF STABLE VIROLOGICAL RESPONSE TO ANTI-VIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C ACCOMPANYING HIV INFECTION | 2013 |
|
RU2558793C2 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
METHOD OF TREATING CHRONIC HEPATITIS IN CHILDREN | 2014 |
|
RU2553179C1 |
METHOD FOR TREATING CHRONIC VIRAL HEPATITIS | 2004 |
|
RU2265447C1 |
Authors
Dates
2010-09-27—Published
2009-07-13—Filed